arrow
X

Xiaoting Wu

University of Oulu
H指数:44
被引数:6,508

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tolerability and Efficacy of an Enteral Formula Containing Partially Hydrolyzed Guar Gum in Patients Following Gastrointestinal Surgery: A Prospective, Multicenter, Open-Label, Randomized Controlled Study

含部分水解瓜尔胶的肠内配方在胃肠道手术后患者中的耐受性与疗效:一项前瞻性、多中心、开放标签、随机对照研究

2025-12-080
PRE
Pretreatment Viral Quasispecies Characteristics and Evolutionary Phases Correlate with HBsAg Seroconversion in Peginterferon-alfa-2a-Treated Children with HBeAg-Positive Chronic Hepatitis B

治疗前病毒准种特征及进化阶段与聚乙二醇干扰素α-2a治疗、HBeAg阳性的慢性乙型肝炎儿童中HBsAg血清学转换相关

2025-10-120
PRE
Dietary Supplementation with Multi-strain Probiotic Formulation (Bifidobacterium B8101, Lactobacillus L8603, Saccharomyces bayanus S9308, and Enterococcus SF9301), Betaine or their Combination Promotes Growth Performance Via Improving Intestinal Development in Broilers

通过补充多菌株益生菌制剂(Bifidobacterium B8101、Lactobacillus L8603、Saccharomyces bayanus S9308和Enterococcus SF9301)、甜菜碱或其组合,可促进肉鸡的生长性能,其作用机制是通过改善肠道发育。

2024-12-230
PRE
IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients (pts) with advanced solid tumors and breast cancer (BC): Results from a phase I study

IBI354(抗HER2抗体药物偶联物[ADC])在晚期实体瘤和乳腺癌(BC)患者(pts)中的研究:一项I期研究的成果

2024-09-010
PRE